On January 20, 2026, IQVIA Holdings Inc. (NYSE:IQV), a preeminent global provider of clinical research services and healthcare intelligence, announced that it will release its financial results for the fourth quarter and full year of 2025 on February 5, 2026. The company intends to share these results before the market opens, providing investors and analysts with critical insights into the company’s performance over the past year.

The management team at IQVIA will hold a conference call and webcast on the same day at 9:00 a.m. Eastern Time, offering stakeholders an opportunity to engage directly with the company's executives. This event will give attendees a chance to hear first-hand about the company’s financial health and strategic direction.

2. How to Access the Conference Call

For interested parties wishing to participate in the conference call, prior registration is required. Participants can register through the IQVIA Investor Relations website. Following registration, participants will receive a confirmation email containing essential details, including a unique passcode and registrant ID, which will facilitate access to the call.

The live event will also be available via a webcast, which can be accessed on the same Investor Relations platform. For those unable to attend the live session, a replay of the webcast will be available approximately two hours post-event, allowing stakeholders to review the insights shared at their convenience.

3. About IQVIA

Founded on a robust foundation of advanced analytics and healthcare intelligence, IQVIA is recognized as an industry leader in providing comprehensive solutions to the life sciences and healthcare sectors. The company's offerings are enhanced by its proprietary IQVIA Connected Intelligence™, which integrates high-quality health data with cutting-edge technology and AI-driven analytics.

IQVIA's commitment to responsible AI usage is evident in its focus on privacy, regulatory compliance, and patient safety. With a workforce of approximately 91,000 employees across more than 100 countries, IQVIA combines expertise in healthcare, life sciences, data science, and operational excellence to drive innovation in medical treatments, ultimately aiming to improve patient outcomes and public health.

4. Protecting Patient Privacy

A distinguishing feature of IQVIA is its dedication to patient privacy. The company employs a variety of privacy-enhancing technologies to safeguard individual data while still enabling extensive analysis that benefits healthcare stakeholders. This balance between data utility and privacy is essential for advancing the understanding of diseases and improving treatment pathways.

5. Conclusion

As investors await IQVIA's Q4 and full-year 2025 results, the upcoming conference call promises to provide valuable insights into the company’s financial trajectory and strategic initiatives. With a strong focus on innovation, data integrity, and patient safety, IQVIA continues to position itself as a leader in the healthcare intelligence domain. Stakeholders are encouraged to engage with the company during this pivotal announcement to gain a deeper understanding of its ongoing commitment to enhancing global health outcomes.

Original press release